These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Bick U; Ullrich K; Stöber U; Möller H; Schuierer G; Ludolph AC; Oberwittler C; Weglage J; Wendel U Eur J Pediatr; 1993 Dec; 152(12):1012-20. PubMed ID: 8131802 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331 [TBL] [Abstract][Full Text] [Related]
4. Neurocognitive functioning in adults with phenylketonuria: results of a long term study. Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437 [TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance imaging of the brain in phenylketonuria]. Izumi M; Yamazaki H; Nakabayashi H; Owada M No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793 [TBL] [Abstract][Full Text] [Related]
6. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study. Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650 [TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of the brain in phenylketonuria. Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392 [TBL] [Abstract][Full Text] [Related]
10. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria. Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280 [TBL] [Abstract][Full Text] [Related]
11. Brain phenylalanine concentration in the management of adults with phenylketonuria. Moats RA; Koch R; Moseley K; Guldberg P; Guttler F; Boles RG; Nelson MD J Inherit Metab Dis; 2000 Feb; 23(1):7-14. PubMed ID: 10682303 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Pietz J; Meyding-Lamadé UK; Schmidt H Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614 [TBL] [Abstract][Full Text] [Related]
13. Neurological manifestations in adults with phenylketonuria: new cases and review of the literature. Jaulent P; Charriere S; Feillet F; Douillard C; Fouilhoux A; Thobois S J Neurol; 2020 Feb; 267(2):531-542. PubMed ID: 31701331 [TBL] [Abstract][Full Text] [Related]
14. Optimal serum phenylalanine for adult patients with phenylketonuria. Okano Y; Nagasaka H Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552 [TBL] [Abstract][Full Text] [Related]
15. Blood-brain phenylalanine relationships in persons with phenylketonuria. Koch R; Moats R; Guttler F; Guldberg P; Nelson M Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780 [TBL] [Abstract][Full Text] [Related]
16. Proton in vivo spectroscopy of patients with hyperphenylalaninaemia. Hájek M; Hejcmanová L; Prádný J Neuropediatrics; 1993 Apr; 24(2):111-2. PubMed ID: 8327063 [TBL] [Abstract][Full Text] [Related]
17. True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria. Palaiodimou L; Zompola C; Lachanis S; Mylona V; Theodorou A; Papagiannopoulou G; Kotsali-Peteinelli V; Foska A; Kasti A; Skouma A; Tsivgoulis G Neurologist; 2020 Dec; 26(1):20-21. PubMed ID: 33394907 [TBL] [Abstract][Full Text] [Related]
18. [Brain white matter lesions of children with phenylketonuria before and after treatment]. Wang ZX; Zhou ZS; Yu WM Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231 [TBL] [Abstract][Full Text] [Related]
19. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine. Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543 [TBL] [Abstract][Full Text] [Related]
20. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria. Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]